Illumina stock forecast.

Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued.SAN DIEGO, March 30, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders.. The activist investor Carl Icahn has nominated three of his associates to …Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ...Illumina, Inc. (ILMN.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Illumina, Inc. | Nasdaq: ILMN | Nasdaq

Illumina's stock (ILMN) rose in the intraday levels while correcting the main downward trend, as the stock retests the resistance of the secondary trend line in the short term, coinciding with touching the resistance of the 50-day SMA, doubling negative pressures, with negative signals from the RSI despite reaching overbought levels, hinting …

Shares of Illumina stock traded up $5.41 on Monday, reaching $115.20. The stock had a trading volume of 1,341,160 shares, compared to its average volume of 1,663,792. The business’s 50-day ...

ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Illumina Shares Drop on Forecast for 2023 Sales Decline ...Illumina's future is looking a bit dim at the moment. Illumina 's ( ILMN 0.59%) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and ...Dec 1, 2023 · Illumina Stock Forecast 12-06-2023. Forecast target price for 12-06-2023: $ 100.50. Positive dynamics for Illumina shares will prevail with possible volatility of 1.073%. Pessimistic target level: 100.05. Optimistic target level: 101.14. Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic ...Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.

Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $-7.12 · Market Cap. $17.43 B · Shares Outstanding. 158.80 M · Public Float. 158.12 M · Yield. ILMN is not ...

Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios.

Annual Growth Forecast - ILMN vs. TMO. Trefis. Thermo Fisher Scientific Is More Profitable But Comes With Higher Risk. Illumina’s operating margin has slid from 29.3% in 2019 to -90.6% in 2022 ...The average price target for Illumina is $135.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $260.00 ,the lowest forecast is $50.00. The average price target represents 32.91% Increase from the current price of $101.57. Looking at Illumina's most recent earnings report, Q2 2023 revenue stands at $1.176B, a slight increase from Q2 2022's $1.162B. Gross margin dropped to 62.2% from 66.0%. R&D expenses rose to $358M ...Earnings tumbled 81% and lagged forecasts for 26 cents. Sales fell 7% in constant currency. Analysts called for $1.07 billion in sales. ... Illumina Stock Tumbles As Sales, Profits Decline — Why ...A high-level overview of Illumina, Inc. (ILMN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...GH Stock 12 Months Forecast. $46.93. (101.59% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Guardant Health in the last 3 months. The average price target is $46.93 with a high forecast of $64.00 and a low forecast of $27.00. The average price target represents a 101.59% change from the last price of $23.28.The Illumina stock forecast is 347.82019291099 USD for 2024 November 29, Friday; and 1992.926 USD for 2028 November 29, Wednesday with technical analysis. Illumina (ILMN) stock price prediction is 347.82019291099 USD.The Stock Market’s Reaction To The New Illumina CEO. ... CEO coincides with a crucial juncture for the biotech company, as the company also recently revised its full-year forecast, citing a ...Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023. ... The company also forecast adjusted earnings of $1.25 ...Based on 4 Wall Street analysts` predicted price targets for Illumina in the last 12 months, the avarage price target is $234.25. The average price target ...

Oct 4, 2020 · For ILLUMINA INC stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average ILLUMINA INC stock forecast of $117.71, a high forecast of $140.93, and a low forecast of $87.66. The average ILLUMINA INC stock forecast 2028 represents a 17.51% increase from the last price of $100.169998168945.

Simply Wall St. July 22, 2023 at 7:00 AM · 3 min read. Today we're going to take a look at the well-established Illumina, Inc. ( NASDAQ:ILMN ). The company's stock received a lot of attention ...Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript April 25, 2023 Illumina, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.03. Operator: Good day, ladies ...Illumina, Inc. Common Stock is estimated to report earnings on 08/10/2023. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor ...HSBC Adjusts Price Target on Illumina to $235 From $270 Aug. 14: MT JPMorgan Adjusts Illumina Price Target to $190 From $235, Maintains Neutral Rating Aug. 10: MT Citigroup Adjusts Illumina's Price Target to $150 From $180, Keeps Sell Rating Aug. 10Illumina's board named Jacob Thaysen the new CEO of the DNA sequencing company. Thaysen, a 48-year-old longtime executive at medical devices firm Agilent, will step in as CEO on Sept. 25.A high-level overview of Illumina, Inc. (ILMN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022. August 11, 2022. Revenue of $1.16 billion for Q2 2022, up 3% from Q2 2021, and up 5% on a constant currency basis. GAAP diluted loss per share of $ (3.40) for Q2 2022, compared to GAAP diluted earnings per share of $1.26 for Q2 2021; GAAP diluted loss per share for …

For the year, Illumina expects core sales to climb 6%-9% and for Grail revenue to be in the range of $90 million to $110 million. ILMN stock analysts called for $4.97 billion in sales, which would ...

Illumina and S&P 500 Performance During 2007-08 Crisis ILMN stock declined from $87 in August 2008 (its pre-crisis peak) to around $31 in March 2009 (as the markets bottomed out), implying that it ...

Oct 7, 2022 · We believe that Illumina stock (NASDAQ NDAQ +0.9%: ILMN), a gene sequencing company, is currently a better pick than Thermo Fisher Scientific stock (NYSE: TMO), given Illumina’s ILMN 0.0% better ... Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus …Illumina stock recovered Thursday after the company torched its outlook on company-specific and macro headwinds.At the close, ILMN stock sank back below its 50-day line.. X. Illumina is a leader ...The average price target for Illumina is $135.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $260.00 ,the lowest forecast is $50.00. The average price target represents 32.91% Increase from the current price of $101.57. Illumina shareholders re-elect eight of nine Illumina directors. SAN DIEGO, May 25, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of …Illumina’s stock on track for lowest close in 10 years after cutting guidance MarketWatch. Thursday, November 09, 2023. 05:12 PM ET. Illumina shares fall as company cuts forecasts MarketWatch. Friday, October 13, 2023. 02:27 PM ET. Illumina responds to EC Grail divestiture order MarketWatch. Thursday, October 12, 2023. 04:26 PM ETThe stock price has decreased by -51.30% in the last 52 weeks. The beta is 1.16, so Illumina's price volatility has been higher than the market average. Beta (1Y)Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57.Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ... We would like to show you a description here but the site won’t allow us.

ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Illumina Shares Drop on Forecast for 2023 Sales Decline ...In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Illumina shares. Our integrated forecast predicts a peak price of $117.68 in the forthcoming 30 days, indicating the zenith of the stock's potential performance.2 Wall Street analysts have issued 1 year price targets for illumin's stock. Their ILLM share price targets range from $2.50 to $2.50. On average, they anticipate the company's share price to reach $2.50 in the next twelve months. View analysts price targets for ILLM or view top-rated stocks among Wall Street analysts.Instagram:https://instagram. nu bank stockbest etfs right nowge spin offbetterment vs schwab Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the … short stocks listsequoia financial 2 days ago · The latest Illumina stock prices, stock quotes, news, and ILMN history to help you invest and trade smarter. ... The 54 analysts offering price forecasts for Illumina have a median target of 255. ... healthcare loans for houses Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023. ... The company also forecast adjusted earnings of $1.25 ...Oct 26, 2023 · Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2026 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 0.59%, beckoning investors to consider amplifying their portfolios.